Ding Zhou

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

Janeta Popovici-Müller, René M. Lemieux, Erin Artin et al. · ACS Medicinal Chemistry Letters · 2018 · 422 citations · Full text

Idh1 Mutant Cancers, Somatic Point Mutations, Somatic Variant +14

Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma

Zenon Konteatis, Erin Artin, Brandon Nicolay et al. · ACS Medicinal Chemistry Letters · 2020 · 174 citations · Full text

Mutant Isocitrate Dehydrogenase, High-grade Gliomas, Glioma +18

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

Christine L. Clouser, Jay Chauhan, Matthew A. Bess et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 94 citations · Full text

Medicinal Chemistry, Medicine, Drug Discovery +11

Synthesis and Properties of Aminopropyl Nucleic Acids

Ding Zhou, Irene M. Lagoja, Jef Rozenski et al. · ChemBioChem · 2005 · 35 citations

Aminopropyl Nucleic Acids, Medicinal Chemistry, Nucleic Acid Chemistry +12

Phosphonoxins III: Synthesis of α-Aminophosphonate Analogs of Antifungal Polyoxins with Anti-<i>Giardia</i> Activity

Michael D. Staake, Jay Chauhan, Ding Zhou et al. · Organic Letters · 2010 · 23 citations

Phosphonoxin C1, α-Aminophosphonate Analogs, Biosynthesis +11